Global Opioid Induced Constipation Drug Market Forecast 2017-2025

Publisher Name :
Date: 24-Sep-2017
No. of pages: 125

Key Findings

Global Opioid-Induced Constipation (OIC) drug market is estimated to grow at a CAGR of 7.08% during the forecast period of 2017 - 2025. The major drivers responsible for the market growth include the growing use of opioid, rising geriatric population, growing opioid prescription in North America and Europe, detection of safety threats and the easy availability of improved and effective OIC drugs. Some of the commonly prescribed opioids are Percocet, Vicodin, and codeine.

Market Insights

The global Opioid-Induced Constipation (OIC) drug market segments include drug type and prescription type. The drug types are further classified into Methyl naltrexone Bromide, Naloxegol, and Lubiprostone. The prescription types are further classified into prescribed and over the counter. Of these, the Over the counter segment is dominating the market as a doctor's prescription is not required to buy the drugs which make its access much easier.

Regional Insights

Geographically, the global opioid-induced constipation (OIC) market encompasses regions like the North America, Asia Pacific, Europe and Rest of World. Of these, the North American market is expected to dominate the global OIC drugs market during the forecast period on account of the fact that approximately 50% of the population is suffering from OIC. The countries in this region also have the most developed healthcare systems and medical devices industry in the world. The Federal agencies and private firms are equally supporting the market by providing access to the best medical facilities to the consumers. Growing lifestyle oriented diseases, increase in healthcare spending and technological advancement in cardiology are the factors responsible for the growth of this market.

Competitive Insights

Product launch is the key strategy adopted by the various market players of global opioid-Induced Constipation (OIC) drug market. The players are also engaging in partnerships, mergers, and acquisitions to withhold their stand in the market. For example, Ironwood Pharmaceuticals Inc entered into an agreement with Bionomics Limited in the year 2016 to fund their drug discovery processes. In April 2017, Finch Therapeutics and Takeda Pharmaceutical Company Limited signed a collaboration to develop FIN-524, a live biotherapeutic product which is currently at the preclinical research stage. Some of the other pioneering companies for this market include Daiichi Sankyo Co Ltd, Pfizer, Progenics Pharmaceuticals Inc, Shionogi & Co Ltd, Allergan Plc, Nektar Therapeutics, Purdue Pharma L.P, S.L.A. Pharma Ag, Mundipharma International Limited, Ono Pharmaceutical Co., Ltd, Takeda Pharmaceutical Company Limited, Theravance Biopharma Inc, Valeant Pharmaceuticals International, Cosmo Pharmaceuticals Sa, Daewoong Pharmaceutical Co., Ltd and C.B. Fleet Company Inc.

Global Opioid Induced Constipation Drug Market Forecast 2017-2025

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study and Forecasting Years
2. Research Methodology
2.1. Sources of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
4. Market Overview
4.1. Market Definition
4.2. Key Market Insights
4.3. Attractive Investment Scenario
4.4. Positioning of Key Oic Drugs Manufacturers In The Market
4.5. Market Drivers
4.5.1. Rising Use of Opioid
4.5.2. Increasing Geriatric Population
4.5.3. Increasing Opioids Prescription In North America and Europe
4.5.4. Easy Availability of Improved and Effective Oic Drugs
4.6. Restraints
4.6.1. Research On Pain and Next Generation Analgesics
4.6.2. Side Effects of Oic Drugs
4.6.3. Unawareness and Ignorance Among Patients
4.7. Opportunity
4.7.1. Rising Demand For Oic Drugs From Apac Market
4.7.2. Increasing Use of Opioids
4.8. Challenges
4.8.1. Large Number of Considerations While Using Opioids
5. Global Oic Drug Market By Drug Type 2017-2025 ($ Million)
5.1. Overview
5.1.1. Methyl Naltrexone Bromide
5.1.2. Lubiprostone
5.1.3. Naloxegol
5.2. Pipeline Drug Analysis: Phase 3: Naldemedine (Year of Launch To 2022 $ Million)
5.3. Pipeline Drug Analysis: Phase 2: Alvimopan, Dolcanatide (Qualitative Information)
5.4. Pipeline Drug Analysis: Phase 3: Elobixibat (Year of Launch To 2022 $ Million)
6. Global Oic Drugs Market By Prescription Type 2017-2025 ($ Million)
6.1. Prescribed Drugs
6.1.1. Branded
6.1.2. Generic
6.2. Over The Counter Drugs
7. Key Analytics
7.1. Porters Five Force Model
7.1.1. Intensity of Competitive Rivalry
7.1.2. Bargaining Power of Suppliers
7.1.3. Bargaining Power of Buyers
7.1.4. Threat of Substitute Products
7.1.5. Threat of New Entrants
7.2. Vendor Landscape
7.3. Opportunity Matrix
8. Global Oic Drugs Market By Geography 2017-2025 ($ Million)
8.1. North America
8.1.1. Us
8.1.2. Canada
8.2. Europe
8.2.1. Uk
8.2.2. Germany
8.2.3. Rest of The Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. Rest of Asia Pacific
8.4. Rest of The World
8.4.1. Middle East and Africa
8.4.2. Latin America
8.4.3. Rest of The Row
9. Company Profile
9.1. Ironwood Pharmaceuticals Inc
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Strategic Moves
9.1.4. Scot Analysis
9.2. Daiichi Sankyo Co Ltd
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Strategic Moves
9.2.4. Scot Analysis
9.3. Pfizer
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Strategic Moves
9.3.4. Scot Analysis
9.4. Progenics Pharmaceuticals Inc
9.4.1. Overview
9.4.2. Strategic Moves
9.4.3. Scot Analysis
9.5. Shionogi & Co., Ltd.
9.5.1. Overview
9.5.2. Product Portfolio
9.5.3. Strategic Moves
9.5.4. Scot Analysis
9.6. Allergan Plc
9.6.1. Overview
9.6.2. Product Portfolio
9.6.3. Strategic Moves
9.6.4. Scot Analysis
9.7. Nektar Therapeutics
9.7.1. Overview
9.7.2. Product Portfolio
9.7.3. Strategic Moves
9.7.4. Scot Analysis
9.8. Purdue Pharma L.P.
9.8.1. Overview
9.8.2. Product Portfolio
9.8.3. Strategic Moves
9.8.4. Scot Analysis
9.9. S.L.A. Pharma Ag
9.9.1. Overview
9.9.2. Product Portfolio
9.9.3. Scot Analysis
9.10. Mundipharma International Limited
9.10.1. Overview
9.10.2. Product Portfolio
9.10.3. Strategic Moves
9.10.4. Scot Analysis
9.11. Ono Pharmaceutical Co., Ltd.
9.11.1. Overview
9.11.2. Product Portfolio
9.11.3. Strategic Moves
9.11.4. Scot Analysis
9.12. Takeda Pharmaceutical Company Limited
9.12.1. Overview
9.12.2. Product Portfolio
9.12.3. Strategic Moves
9.12.4. Scot Analysis
9.13. Theravance Biopharma Inc
9.13.1. Overview
9.13.2. Product Portfolio
9.13.3. Strategic Moves
9.13.4. Scot Analysis
9.14. Valeant Pharmaceuticals International
9.14.1. Overview
9.14.2. Product Portfolio
9.14.3. Strategic Moves
9.14.4. Scot Analysis
9.15. Cosmo Pharmaceuticals Sa
9.15.1. Overview
9.15.2. Product Portfolio
9.15.3. Strategic Moves
9.15.4. Scot Analysis
9.16. Daewoong Pharmaceutical Co., Ltd.
9.16.1. Overview
9.16.2. Product Portfolio
9.16.3. Strategic Moves
9.16.4. Scot Analysis
9.17. C.B. Fleet Company, Inc.
9.17.1. Overview
9.17.2. Product Portfolio
9.17.3. Strategic Moves
9.17.4. Scot Analysis
9.18. Sucampo Pharmaceuticals
9.18.1. Overview
9.18.2. Product Portfolio
9.18.3. Strategic Moves
9.18.4. Scot Analysis

List of Tables
Table 1 Global Oic Drug Market By Geography 2017-2025 ($ Million)
Table 2 Pharmacological Approaches To Treat Opioid Induced Constipation
Table 3 Laxatives Used For Opioid Induced Constipation
Table 4 Side Effects of Using Laxatives
Table 5 Patients Unfit For Intake of Opioids
Table 6 Global Oic Drug Market By Drug Type, 2017-2025 ($ Million)
Table 7 Product Profile (Methyl Naltrexone Bromide)
Table 8 Global Methyl Naltrexone Bromide Oic Drug Market By Geography 2017-2025 ($Million)
Table 9 Product Profile (Lubiprostone)
Table 10 Global Lubiprostone Oic Drug Market By Geography 2017-2025 ($Million)
Table 11 Product Profile (Naloxegol)
Table 12 Global Naloxegol Oic Drug Market By Geography 2017-2025 ($Million)
Table 13 Pipeline Product Profile (Naldemedine)
Table 14 Pipeline Product Profile (Alvimopan, Dolcanatide)
Table 15 Pipeline Product Profile (Elobixibat)
Table 16 Global Oic Drug Market By Prescription Type 2017-2025 ($ Million)
Table 17 Product Profile (Lubiprostone)
Table 18 Global Prescribed Oic Drugs Market 2017-2025($ Million)
Table 19 Product Profile (Methyl Naltrexone Bromide)
Table 20 Product Profile (Metamucil)
Table 21 Product Profile (Bisacodyl)
Table 22 Global Over The Counter Oic Drug By Geography 2017-2025($ Million)
Table 23 Global Oic Drugs Market By Geography 2017-2025 ($ Million)
Table 24 North America Oic Drugs Market By Country, 2017-2025($ Million)
Table 25 Europe Oic Drug Market By Countries 2017-2025 ($ Million)
Table 26 Asia Pacific Oic Drug Market By Countries 2017-2025 ($ Million)
Table 27 Rest of World Oic Drug Market 2017-2025 ($ Million)

List of Figures
Figure 1 Global Oic Drugs Market 2017-2025 ($ Million)
Figure 2 Global Oic Drug Market By Drug Type 2016 and 2025 (%)
Figure 3 Global Oic Drug Market By Prescription Type 2016 (%)
Figure 4 Increasing Number of Opioid Prescription ($ Million)
Figure 5 Reasons For The Growth of Opioid Market.
Figure 6 Therapeutic Opioid Use In Us (G/100,000 Population)
Figure 7 Common Side Effects of Movantik
Figure 8 Major Usage of Opioids
Figure 9 Considerations Taken While The Opioid Usage
Figure 10 Global Methyl Naltrexone Bromide Oic Drug Market 2017-2025 ($ Million)
Figure 11 Global Lubiprostone Oic Drug Market 2017-2025 ($Million)
Figure 12 Global Naloxegol Oic Drug Market 2017-2025 ($ Million)
Figure 13 Global Prescribed Oic Drug Market 2017-2025 ($ Million)
Figure 14 Global Prescribed Branded Oic Drug Market 2017-2025 ($ Million)
Figure 15 Global Prescribed Generic Oic Drug Market 2017-2025 ($ Million)
Figure 16 Global Over The Counter Oic Drug Market 2017-2025 ($ Million)
Figure 17 North America Oic Drugs Market 2017-2025 ($ Million)
Figure 18 Us Oic Drug Market 2017-2025 ($ Million)
Figure 19 Canada Oic Drug Market 2017-2025 ($ Million)
Figure 20 Number of Prescriptions Dispensed For Opioids
Figure 21 Europe Oic Drug Market 2017-2025 ($ Million)
Figure 22 Uk Oic Drug Market 2017-2025 ($ Million)
Figure 23 Germany Oic Drug Market 2017-2025 ($ Million)
Figure 24 Rest of Europe Oic Drug Market 2017-2025($ Million)
Figure 25 Asia Pacific Oic Drug Market 2017-2025 ($ Million)
Figure 26 China Oic Drug Market 2017-2025 ($ Million)
Figure 27 Pharmaceuticals Market Sales Across The Globe (%)
Figure 28 Japan Oic Drug Market 2017-2025 ($ Million)
Figure 29 Rest of Apac Oic Drug Market 2017-2025 ($ Million)
Figure 30 Middle East and Africa Oic Drug Market 2017-2025($ Million)
Figure 31 Latin America Oic Drug Market 2017-2025($ Million)
Figure 32 Rest of Row Oic Drug Market 2017-2025($ Million)
  • Global Gastrointestinal OTC Drugs Market Research Report 2017
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 114
    In this report, the global Gastrointestinal OTC Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal OTC Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe......
  • Gastritis - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 51
    Gastritis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2017, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape. Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gast......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2017
    Published: 07-Nov-2017        Price: US 2000 Onwards        Pages: 154
    Irritable Bowel Syndrome - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape. Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Si......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Gastrointestinal Drug Market 2017 Forecast to 2022
    Published: 06-Nov-2017        Price: US 4880 Onwards        Pages: 121
    Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders. Scope of the Report: This report focuses on the Gastrointestinal Drug in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes......
  • Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Short Bowel Syndrome - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Short Bowel Syndrome for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Short Bowel Syndrome . It enables understand......
  • Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Irritable Bowel Syndrome (IBS) - Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients af......
  • Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 2000 Onwards        Pages: 60
    DelveInsight's, Gastric Ulcers - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Gastric Ulcers. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Gastric Ulcers which can turn out t......
  • Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Nov-2017        Price: US 1500 Onwards        Pages: 40
    DelveInsight's, Helicobacter Pylori Infections - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" report provides comprehensive insights about marketed and Phase III products for the Helicobacter Pylori Infections. The report includes information of marketed products including their product description, patent details, forecasted sales till 2020 & API manufacturer details by country. It also provides a comprehensive understanding of the emerging Phase III therapies for Hel......
  • Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025
    Published: 01-Nov-2017        Price: US 5750 Onwards        Pages: 70
    DelveInsight's "Traveler's Diarrhea - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Traveler's Diarrhea for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Traveler's Diarrhea . It enables understanding......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs